Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT06343038 |
| Title | Targeted Radionuclide Therapy in Metastatic Prostate Cancer Using a New PSMA Ligand Radiolabelled With Terbium-161 (161Tb-SibuDAB) - Dose Identification/Escalation Phase Ia/b Study (PROGNOSTICS) |
| Acronym | PROGNOSTICS |
| Recruitment | Recruiting |
| Gender | male |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | University Hospital, Basel, Switzerland |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | CHE |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| University Hospital Basel | RECRUITING | Basel | 4031 | Switzerland | Details |